Elevated environmental temperature and methamphetamine neurotoxicity

Environmental Research

Volumn 92, Issue 1, 2003, Pages 48-53

  Miller, Diane B ^a   O'Callaghan, James P ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; GLIAL FIBRILLARY ACIDIC PROTEIN; METHAMPHETAMINE; TYROSINE 3 MONOOXYGENASE;

DRUG USER; PHYSIOLOGICAL RESPONSE; TOXICOLOGY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARGYROPHILIA; ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL TEMPERATURE; FEMALE; GLIOSIS; MOUSE; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SILVER STAINING; SYNAPTIC MEMBRANE;

ANIMALIA;

EID: 0037403797     PISSN: 00139351     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0013-9351(02)00051-8     Document Type: Article

References (23)

1. Albers D.S., Sonsalla P.K. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice. pharmacological profile of protective and nonprotective agents J. Pharmacol. Exp. Ther. 275:1995;1104-1114.
2. Askew B.M. Hyperpyrexia as a contributory factor in the toxicity of amphetamine to aggregated mice. Br. J. Pharmacol. 19:1962;245-257.
3. Bowyer J.F., Holson R.R. Methamphetamine and amphetamine neurotoxicity. Chang L.W., Dyer R.S. Handbook of Neurotoxicology. 1995;845-870 Dekker, New York.
4. Bowyer J.F., Davies D.L., Schmued L., Broening H.W., Newport G.D., Slikker W. Jr., Holson R.R. Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J. Pharmacol. Exp. Ther. 268:1994;1571-1580.
5. Bowyer J.F., Schmued L., Harris A., O'Callaghan J.P., Miller D.B., Jakab R.L. Prolonged d-amphetamine (AMPH) exposure produces cortical neurodegeneration, alters mRNA expression, and depletes striatal dopamine in the absence of hyperthermia. Soc. Neurosci. Abs. 27:2001;231.
6. Bowyer J.F., Holson R.R., Miller D.B., O'Callaghan J.P. Phenobarbital and dizocilpine can block methamphetamine-induced neurotoxicity in mice by mechanisms that are independent of thermoregulation. Brain Research. 919:2001;179-183.
7. Casarett, L.J., Doull, J., 1973. Factors influencing toxicology. In: Toxicology, The Basic Sciences of Poisons. MacMillan Co., New York, pp. 133-147.
8. Chadwick I.S., Curry P.D., Linsley A., Freemont A.J., Doran B. Ecstasy 3,4-methylenedioxymethamphetamine (MDMA), a fatality associated with coagulopathy and hyperthermia. Trans. Soc. Med. 84:1991;371-373.
9. Chance M.R.A. Aggregation as a factor influencing the toxicity of sympathomimetic amines in mice. J. Pharmacol. Exp. Ther. 87:1946;214-219.
10. Gordon C.J. Role of environmental stress on the physiological response to chemical toxicants. Environ. Res. 92(1):2003;1-7.
11. Johnson E.A., Miller D.B. Restraint stress and other stress manipulations are neuroprotective against the effects of increased brain concentration of 3,4-methylenedioxymethamphetamine (d-MDMA) in C57B1/6J mouse because of altered distribution. Soc. Neurosci. Abstr. 27:2001;89.
12. Johnson E.A., Sharp D.S., Miller D.B. Restraint as a stressor in mice. against the dopaminergic neurotoxicity of D-MDMA, low body weight mitigates restraint-induced hypothermia and consequent neuroprotection Brain Res. 875:2000;107-118.
13. Logan B.J., Laverty L., Sanderson W.D., Yee Y.B. Differences between rats and mice in MDMA (methylenedioxymethamphetamine) neurotoxicity. Eur. J. Pharmacol. 12:1988;227-234.
14. Miller D.B., O'Callaghan J.P. Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse. J. Pharmacol. Exp. Ther. 270:1994;752-760.
15. Miller D.B., O'Callaghan J.P. Neurotoxicity of d-amphetamine in the C57BL/6J and CD-1 mouse. interactions with stress and the adrenal system Ann. N. Y. Acad. Sci. 801:1996;148-167.
16. O'Callaghan J.P. Quantification of glial fibrillary acidic protein. comparison of slot-immunobinding assays with a novel sandwich Elisa Neurotoxicol. Teratol. 13:1991;275-281.
17. O'Callaghan J.P., Miller D.B. Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse. J. Pharmacol. Exp. Ther. 270:1994;741-751.
18. O'Callaghan J.P., Miller D.B. Neurotoxic effects of substituted amphetamines in rats and mice. Massare E.J. Handbook of Neurotoxicology. Vol. 2:2001;269-301 Humana Press, Totowa, NJ.
19. O'Callaghan J.P., Miller D.B., Reinhard J.F. Characterizaton of the origins of astrocyte response to injury using the dopaminergic neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Brain Res. 521:1990;73-80.
20. O'Callaghan J.P., Miller D.B., Reinhard J.F. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced damage of striatal dopaminergic fibers attenuates subsequent astrocyte response to MPTP. Neurosci. Lett. 117:1990;228-233.
21. Randall T. Ecstasy-fueled "rave" parties become dances of death for English youths. JAMA. 268:1992;1505-1506.
22. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Olson B.J., Klenk D.C. Measurement of protein using bicinchoninic acid. Anal Biochem. 150:1985;76-85.
23. Swinyard E.A., Clark L.D., Miyahara J.T., Wold H.H. Studies on the mechanism of amphetamine toxicity in aggregated mice. J. Pharmacol. Exp. Ther. 256:1961;506-512.